A double-blind, multi-center extension study to evaluate the safety and efficacy of Q8003 in patients with acute moderate to severe pain

Trial Profile

A double-blind, multi-center extension study to evaluate the safety and efficacy of Q8003 in patients with acute moderate to severe pain

Completed
Phase of Trial: Phase III

Latest Information Update: 23 May 2012

At a glance

  • Drugs Morphine/oxycodone (Primary)
  • Indications Pain
  • Focus Adverse reactions; Registrational
  • Most Recent Events

    • 09 Jun 2008 Status change from recruiting to completed, according to clinicaltrials.gov.
    • 10 Dec 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top